Loading clinical trials...
Loading clinical trials...
Descriptive pharmacoepidemiological study on the use of Symbicort Turbuhaler in the treatment of asthma in France and impact of a new therapeutic strategy on the compliance and control of asthma
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AstraZeneca
NCT07301736 · Asthma
NCT06732141 · Asthma
NCT06932263 · Asthma
NCT07245576 · Asthma, COPD
NCT07160868 · Asthma (Diagnosis), OSA - Obstructive Sleep Apnea, and more
Research Site
Dessenheim, Alsace
Research Site
Duppigheim, Alsace
Research Site
Haguenau, Alsace
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions